Alvotech (ALVO)
5.50
-0.28
(-4.84%)
USD |
NASDAQ |
Oct 12, 16:00
5.50
0.00 (0.00%)
After-Hours: 17:12
Alvotech EPS Diluted (Quarterly) : -0.1873 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1873 |
| March 31, 2026 | 0.0031 |
| December 31, 2025 | -0.3558 |
| September 30, 2025 | -0.0174 |
| June 30, 2025 | 0.1062 |
| March 31, 2025 | 0.3634 |
| December 31, 2024 | -0.2219 |
| September 30, 2024 | -0.0378 |
| June 30, 2024 | 0.2334 |
| March 31, 2024 | -0.8198 |
| December 31, 2023 | -1.036 |
| September 30, 2023 | -0.7047 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.7185 |
| March 31, 2023 | -1.052 |
| December 31, 2022 | -1.289 |
| September 30, 2022 | -0.0346 |
| March 31, 2022 | -2.463 |
| December 31, 2021 | -0.1264 |
| September 30, 2021 | -2.602 |
| June 30, 2021 | -0.0072 |
| March 31, 2021 | 0.2262 |
| December 31, 2020 | -0.2956 |
| September 30, 2020 | -0.0524 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Regeneron Pharmaceuticals, Inc. | 12.23 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -66.82M |
| Revenue (Quarterly) | 105.77M |
| Total Expenses (Quarterly) | 172.59M |
| Enterprise Value | 3.371B |
| Gross Profit Margin (Quarterly) | 50.65% |
| Profit Margin (Quarterly) | -63.17% |
| Earnings Yield | -10.13% |
| Operating Earnings Yield | 2.52% |
| Normalized Earnings Yield | -10.13 |